BioPharm America- MassBio to Host Partnering Event
MassBio, in partnership with EBD Group, the leading partnering firm for the life sciences industry, will host the sixth annual BioPharm America™ conference September 17-19 at the Westin Boston Waterfront.
“BioPharm America brings industry executives from around the world to the best place for life sciences – the Massachusetts supercluster,” said Robert K. Coughlin, President & CEO of MassBio. “This event is a great opportunity for the MassBio membership to showcase their cutting-edge innovations and develop new partnerships.”
BioPharm America has become a major hub for engaging new partners in the life sciences industry. The event attracts top dealmakers from biotech and pharma, as well as leading bankers and VCs. Powered by EBD Group’s sophisticated partnering system, partneringONE®, the event enables delegates to efficiently start partnerships with companies across the life sciences value chain.
BioPharm America will kick off its 2013 program with an Opening Plenary entitled “Strategic R&D Planning: The Chameleon Rubik’s Cube” on Tuesday, September 17. The plenary features moderator Vaughn Kailian, Managing Director of MPM Capital and includes speakers James Hoyes, President of EMD Serono; John Maraganore, CEO of Alnylam; David Meeker, President and CEO of Genzyme; and Barbara Yanni, VP and Chief Licensing Officer at Merck. The panel will discuss long-term pipeline planning in drug development which can be likened to a Rubik’s cube that changes colors with its surroundings.
Other highlights of the 2013 program include a new spin on a conference favorite, Doug MacDougall’s “The Perfect Pitch: Do you have what it takes to win over investors?” and the workshop “Why can’t big pharma invest in my company?” moderated by David Collier, CEO of Velocity Pharmaceutical Development.
“This year we have changed the program to include a full afternoon of roundtable discussions to engage conference attendees as well as the executive panelists,” said Carola Schropp, President of EBD Group. “The new roundtable format will promote discussion and interaction among discussion leaders and audience members, and therefore provide yet another networking opportunity for participants.”